Qiu, Chengxiang http://orcid.org/0000-0002-6346-8669
Martin, Beth K. http://orcid.org/0000-0002-9661-014X
Welsh, Ian C.
Daza, Riza M. http://orcid.org/0000-0003-1635-8675
Le, Truc-Mai
Huang, Xingfan
Nichols, Eva K.
Taylor, Megan L. http://orcid.org/0009-0002-2511-1498
Fulton, Olivia http://orcid.org/0009-0007-3153-5373
O’Day, Diana R.
Gomes, Anne Roshella
Ilcisin, Saskia
Srivatsan, Sanjay
Deng, Xinxian http://orcid.org/0000-0002-5007-218X
Disteche, Christine M. http://orcid.org/0000-0002-5433-495X
Noble, William Stafford http://orcid.org/0000-0001-7283-4715
Hamazaki, Nobuhiko
Moens, Cecilia B.
Kimelman, David http://orcid.org/0000-0002-9261-4506
Cao, Junyue
Schier, Alexander F.
Spielmann, Malte http://orcid.org/0000-0002-0583-4683
Murray, Stephen A. http://orcid.org/0000-0002-0594-1702
Trapnell, Cole http://orcid.org/0000-0002-8105-4347
Shendure, Jay http://orcid.org/0000-0002-1516-1865
Article History
Received: 5 April 2023
Accepted: 15 January 2024
First Online: 14 February 2024
Competing interests
: J.S. and C.T. are co-founders and scientific advisors to Scale Biosciences. J.S. is also a scientific advisory board member, consultant and/or co-founder of Cajal Neuroscience, Guardant Health, Maze Therapeutics, Camp4 Therapeutics, Phase Genomics, Adaptive Biotechnologies, Sixth Street Capital, Pacific Biosciences, and Prime Medicine. The other authors declare no competing interests.